Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correspondence of increased debrisoquine 4-monooxygenase activity with seizure-susceptibility in Mongolian gerbils.

Journal of the neurological sciences - 1 Jan 1994

Iwahashi K, Suwaki H, Matsuo Y, Ichikawa Y, Hosokawa K

Abstract excerpt

Four drug-metabolizing activities in Wistar rat and Mongolian gerbil liver microsomes were investigated to clarify the biochemical basis of convulsions. No significant associations were observed between the susceptibility to the tonic-clonic seizures in Mongolian gerbils and the drug-metabolizing enzymatic activities of p-nitroanisole O-demethylase, aminopyrine demethylase and benzo[a]pyrene-3-monooxygenase....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Rats, Wistar
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Electroencephalography

Share to Genetic Predisposition to Disease

Share to Mixed Function Oxygenases

Share to Seizures

Source

Identifiers

PMID: 8133306
DOI: 10.1016/0022-510x(94)90150-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correspondence of increased debrisoquine 4-monooxygenase activity with seizure-susceptibility in Mongolian gerbils.PMID 8133306Read ↗

Debrisoquine oxidation in Parkinson's disease.Semantic proximity Read ↗

Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.Semantic proximity Read ↗

Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.Semantic proximity Read ↗

Enhanced lipid peroxidation in epileptics with null genotype of glutathione S-transferase M1 and intractable seizure.Semantic proximity Read ↗

Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.Semantic proximity Read ↗

Debrisoquine metabolism in Chinese patients with Alzheimer's and Parkinson's diseases.Semantic proximity Read ↗

Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.Semantic proximity Read ↗

Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.Semantic proximity Read ↗

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.Semantic proximity Read ↗

A protocol for the safe administration of debrisoquine in biochemical epidemiologic research protocols for hospitalized patients.Semantic proximity Read ↗

Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs.Semantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.